← Back to Clinical Trials
Recruiting NCT06758050

NCT06758050 Effect of Core Exercises on Patellofemoral Pain Syndrome

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06758050
Status Recruiting
Phase
Sponsor Cairo University
Condition Patellofemoral Pain Syndrome
Study Type INTERVENTIONAL
Enrollment 44 participants
Start Date 2024-08-04
Primary Completion 2025-01-15

Trial Parameters

Condition Patellofemoral Pain Syndrome
Sponsor Cairo University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 44
Sex ALL
Min Age 18 Years
Max Age 35 Years
Start Date 2024-08-04
Completion 2025-01-15
Interventions
Core strengthening exercisesTraditional treatment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

the goal of this interventional study is to Investigate the effect of core strengthening exercises on pain, strength, function, and balance in patients with PFPS.

Eligibility Criteria

Inclusion Criteria: 1. Patients of both genders with an age range of 18- 35 years old. 2. Gradual development of pain in the front of the knee lasting more than 12 weeks. 3. Patients with body mass index 18- 25 kg m2. 4. Pain is aggravated by at least 2 of the following activities: jumping, running, prolonged sitting, stair climbing, kneeling, and squatting. 1. Positive patellar grinding test. 2. Insidious onset of symptoms, unrelated to a traumatic damage. Exclusion Criteria: 1. Traumatic patellar subluxation or dislocation. 2. A history of any of the following conditions: meniscal or other intra articular pathologic conditions; cruciate or collateral ligament involvement. 3. Any lower limb bony or congenital deformities. 4. Previous knee and hip joint surgeries. 5. Osteoarthritis in the ankle, knee, or hip joints. 6. Conditions that affect muscle strength such as diabetes mellitus or rheumatoid arthritis.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology